Deal Dispatch: Abbott, TPG, Lonza Make Major Moves; M&M Custard & New Fortress Energy Struggle - Abbott Laboratories ( NYSE:ABT ) , Comcast ( NASDAQ:CMCSA )
Swiss life sciences giant Lonza Group is shopping its capsules and health ingredients division, and the shortlist is full of private equity heavy-hitters. In the running: Altaris, Lone Star Funds, and One Rock Capital. Expected sale price: At least €2.5 billion ( US$2.8 billion ) .
Top 2 Healthcare Stocks Every New Investor Should Know
These healthcare stocks have long-term and profitable growth runways.
2 Fantastic Dividend Stocks to Buy and Hold Forever
These companies have been raising their payouts for a combined 101 consecutive years.
Why Exact Sciences Rallied Over 50% This Week
The company received a buyout offer from Abbot Labs.
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics - Abbott Laboratories ( NYSE:ABT ) , Exact Sciences ( NASDAQ:EXAS )
Abbott Laboratories ( NYSE:ABT ) agreed on Thursday to acquire cancer screening company Exact Sciences Corp ( NASDAQ:EXAS ) for $105 per common share, representing a total equity value of approximately $21 billion and an estimated enterprise value of $23 billion.
Why Exact Sciences Stock Blasted Nearly 24% Higher Today
A strategic investor is reportedly in advanced talks to purchase the company.
AbbVie Stock Falls 4% -- What Investors Need to Know
It's no reason to stay up at night.
2 Sweet Dividend Stocks to Buy to Satisfy Your Craving for Passive Income
Dividend stocks can strengthen your portfolio during any market environment.
2 Strong Healthcare Stock Picks for Dividend Investors
These top dividend payers could enrich a long-term investor's portfolio.
Cardiac Arrest Treatment Market Set for Remarkable Growth Driven by Advanced Emergency Care and Rising Cardiac Cases: Verified Market Research®
Lewes, Delaware, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- The Global Cardiac Arrest Treatment Market Size projected to grow at a CAGR of 4.50% from 2024 to 2031, according to a new report published by Verified Market Research®.
1 Spectacular Growth Stock Down 20% to Buy Right Now, According to Wall Street
Shares are near their lowest levels in five years.
2 Top Dividend Stocks to Buy and Hold Forever
These companies have already handsomely rewarded longtime shareholders, and it's not too late to join the party.
3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November
These stocks aren't popular right now, but their strong underlying businesses make them hot deals to pounce on.
Baby Food Market is expected to generate a revenue of USD 127.66 Billion by 2032, Globally, at 6.20% CAGR: Verified Market Research®
Lewes, Delaware, Nov. 04, 2025 ( GLOBE NEWSWIRE ) -- The Global Baby Food Market Size is projected to grow at a CAGR of 6.20% from 2026 to 2032, according to a new report published by Verified Market Research®.
2 Healthcare Stocks for Individual Investors With a 10-Year Time Horizon
Healthcare has been an extraordinarily resilient industry to put cash to work in through the years.
Global Microfluidics Market to Surpass USD 32.67 Billion by 2029 | MarketsandMarkets™
Delray Beach, FL, Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- The global microfluidics market, valued at US$21.36 billion in 2023, stood at US$22.43 billion in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$32.67 billion by the ...
Abner Herrman & Brock Sours on Intuitive Surgical
Abner Herrman & Brock LLC ( AHB ) reduced its stake in Intuitive Surgical ( NASDAQ:ISRG ) by almost 10,000 shares, worth over $4.5 million, during the quarter ended September 30, 2025.According to its October 14, 2025 SEC filing, Abner Herrman & Brock trimmed its position in Intuitive Surgical ( ...
Should You Buy DexCom Stock Before Oct. 31?
The company hasn't had a great year. Is it about to turn things around?
The Zacks Analyst Blog Highlights International Business Machines, Micron and Abbott
Zacks analysts highlight IBM, Micron, and Abbott for their innovation-driven growth, solid fundamentals, and evolving market strategies.
Is the Market Bullish or Bearish on Abbott Laboratories? - Abbott Laboratories ( NYSE:ABT )
Abbott Laboratories's ( NYSE:ABT ) short interest as a percent of float has risen 6.67% since its last report. According to exchange reported data, there are now 19.36 million shares sold short, which is 1.12% of all regular shares that are available for trading.
Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption?
DXCM's Q3 results are likely to benefit from rising G7 use, early Stelo traction and expanding access across Type 2 diabetes markets.
Implantable Heart Pacemaker Market is expected to generate a revenue of USD 6.19 Billion by 2031, Globally, at 3.30% CAGR: Verified Market Research®
Lewes, Delaware, Oct. 28, 2025 ( GLOBE NEWSWIRE ) -- The Global Implantable Heart Pacemaker Market Size is projected to grow at a CAGR of 3.30% from 2024 to 2031, according to a new report published by Verified Market Research®.
Assertio Announces Leadership Transition
Appoints Industry Veteran and Current Director Mark L. Reisenauer as CEO, Effective Immediately ...
Assertio Announces Leadership Transition - Assertio Holdings ( NASDAQ:ASRT )
Appoints Industry Veteran and Current Director Mark L. Reisenauer as CEO, Effective Immediately Company Will Report Third Quarter Results on November 10, 2025 and Expects to Update Guidance Within the Current Range at That Time
Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?
Englander seems to have had several good reasons to aggressively buy shares of this big drugmaker.
Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade
Between growth and dividends, these companies have plenty to offer.
A Look Into Abbott Laboratories Inc's Price Over Earnings - Abbott Laboratories ( NYSE:ABT )
In the current market session, Abbott Laboratories Inc. ( NYSE:ABT ) share price is at $128.64, after a 0.86% increase. Moreover, over the past month, the stock fell by 3.92%, but in the past year, increased by 10.38%.
Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains
Abbott posts strong Q3 growth across key segments, but tariff pressures and weak Diagnostics weigh on near-term momentum.
Analyst See Noise In Q3 P&L, Affirms Abbott's Medtech Strength - Abbott Laboratories ( NYSE:ABT )
Abbott Laboratories ( NYSE:ABT ) reported muted sales in the third quarter on Wednesday and narrowed its fiscal 2025 guidance. The company reported third-quarter sales of $11.37 billion, slightly missing the consensus of $11.40 billion.
These Analysts Revise Their Forecasts On Abbott Following Q3 Results - Abbott Laboratories ( NYSE:ABT )
Abbott Laboratories ( NYSE:ABT ) reported muted sales in the third quarter and narrowed fiscal 2025 guidance on Wednesday. The company reported third-quarter sales of $11.37 billion, slightly missing the consensus of $11.40 billion. The U.S.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Investors should be able to count on these stocks to deliver steady and growing income over the long term.
Company News for Oct 16, 2025
Companies In The News Are: HWC, PGR, ABT, ASML.
Gold Gains Over 1%; Abbott Shares Fall After Q3 Results - Abbott Laboratories ( NYSE:ABT ) , Aqua Metals ( NASDAQ:AQMS )
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Wednesday. The Dow traded up 0.06% to 46,299.96 while the NASDAQ climbed 0.52% to 22,639.61. The S&P 500 also rose, gaining, 0.33% to 6,666.08. Communication services shares jumped by ...
Bank Earnings Lift Wall Street, Gold Hits $4,200: What's Moving Markets Wednesday? - Bank of America ( NYSE:BAC )
Wall Street rose on Wednesday, with investor optimism lifted by strong bank and corporate earnings alongside growing expectations for further Federal Reserve rate cuts - keeping trade concerns sidelined for now. The S&P 500 climbed 0.4% to 6,680, putting it within a single percentage point of ...
Abbott Laboratories Remains In Favor With London Investment Manager, New Filing Shows
CCLA Investment Management disclosed a purchase of 66,275 shares of Abbott Laboratories ( NYSE:ABT ) , estimated at ~$8.70 million based on the quarterly average price, in its SEC filing for the period ended September 30, 2025, filed on October 14, 2025.According to a filing with the Securities ...
Abbott's Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Climbs
ABT's Q3 earnings meet expectations as revenues climb 6.9% year over year, driven by double-digit gains in Medical Devices.
1 No-Brainer Dividend Stock to Buy and Hold Forever
This is about as safe as a dividend can be.
Why Is Abbott Laboratories Stock Falling Today? - Abbott Laboratories ( NYSE:ABT )
Abbott Laboratories ( NYSE:ABT ) stock fell after the company reported muted sales in the third quarter and narrowed fiscal 2025 guidance. The company reported third-quarter sales of $11.37 billion, slightly missing the consensus of $11.40 billion.
Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus-Analyst Warns US 'Going Broke Slowly' - SPDR S&P 500 ( ARCA:SPY )
U.S. stock futures advanced on Wednesday following Tuesday's mixed close. Futures of major benchmark indices were higher. Among the big banks that reported on Tuesday, surpassing analyst expectations were Wells Fargo & Co. ( NYSE:WFC ) , Citigroup Inc. ( NYSE:C ) , JPMorgan Chase & Co. ( NYSE:JPM ...
Dow Jumps Over 200 Points Following Strong Bank Earnings: Investor Fear Eases Slightly, But Greed Index Remains In 'Fear' Zone - JPMorgan Chase ( NYSE:JPM )
The CNN Money Fear and Greed index showed some easing in the overall fear level, while the index remained in the "Fear" zone on Tuesday.
Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Wednesday - Abbott Laboratories ( NYSE:ABT )
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Bank of America Corp. ( NYSE:BAC ) to report quarterly earnings at 95 cents per share on revenue of $27.50 billion before the opening bell, ...
Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Abbott Laboratories ( NYSE:ABT )
Abbott Laboratories ( NYSE:ABT ) will release earnings results for the third quarter, before the opening bell on Wednesday, Oct. 15. Analysts expect the North Chicago, Illinois-based company to report quarterly earnings at $1.30 per share, up from $1.21 per share in the year-ago period.
Top Stocks Earnings Playbook: Fastenal, ASML, TSMC and More - Taiwan Semiconductor ( NYSE:TSM )
Retail investors are preparing for the kick-off of the third-quarter earnings season, with big banks and other top stocks reporting this week. Here's a look at some retail favorites that individual investors will be watching. FAST stock is moving. See the real-time price action here.
Cramer's week ahead: Earnings season kicks off with reports from big banks
CNBC's Jim Cramer walked investors through an earnings-heavy week on Wall Street.
Abbott to Report Q3 Earnings: Medical Devices Arm in Focus
ABT's Q3 results may show strength in Medical Devices and Nutrition, offsetting softness in Diagnostics.
Levin Papantonio Attorneys to Lead Key Sessions at MTMP Fall Conference, Highlighting Referral Opportunities in High-Profile Litigations
Levin Papantonio attorney Sara Papantonio speaks to an audience of mass torts attorneys at the MTMP Spring 2025 conference. She will be updating attorneys on the NEC Preterm Infant Formula MDL at MTMP Fall 2025 at the Bellagio Hotel & Casino in Las Vegas, October 21-23.
A Congress Member Sold Up To $300K In A.O. Smith Stock: Here's What You Need To Know - Abbott Laboratories ( NYSE:ABT ) , AbbVie ( NYSE:ABBV )
A October filing shows that Representative Julie Johnson reported a sale in A.O. Smith ( NYSE:AOS ) , valued between $20,020 and $300,000. The transaction date is listed as September 25, 2025, with the report published on October 7, 2025. At present, A.O. Smith shares are trading up 1.99% at ...
Channel Medsystems Appoints Healthcare Executive Skip Baldino to Board of Directors
BERKELEY, Calif., Oct. 08, 2025 ( GLOBE NEWSWIRE ) -- Channel Medsystems, Inc., a privately held company dedicated to advancing women's health with innovative solutions, announced today the appointment of Skip Baldino to its Board of Directors.
3 Dividend Stocks to Double Up On Right Now
The time is right for buying more of these great dividend stocks.
The Zacks Analyst Blog Highlights Advanced Micro Devices, Abbott Laboratories and Micron Technology
AMD, Abbott and Micron showcase strong momentum as AI demand, medical innovation and memory recovery drive growth prospects.
